Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | FAAH | O00519 | 5/20 | 0.39 |
| ▸ | CES1 | P23141 | 5/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | LYPLA1 | O75608 | 2/20 | 0.33 |
| ▸ | LYPLA2 | O95372 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8189879 | 0.91 | CA2 (0.56) | CA2FAAHCES1CES2ESR1 | |
| SCHEMBL1149186 | 0.90 | CA2 (0.38) | CA2FAAHCES1CES2 | |
| SCHEMBL8778834 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL5383600 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL8778722 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL18643527 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL8778782 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL7739945 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL5384235 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 | |
| SCHEMBL8778820 | 0.82 | CA2 (0.62) | CA2FAAHCES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6503938-B1 | Treatment of estrogen related disease or tumor, including prostatic hyperplasia, breast cancer, endometrial carcinoma, anovulatory infertility, melanoma or osteoporosis | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-01-07 | — | — | US | disclosed |
| US-6147105-A | USE IN THE TREATMENT OF ESTROGEN-RELATED DISEASES | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-11-14 | — | — | US | disclosed |